Naviter Wealth’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.49M Buy
47,793
+8,978
+23% +$1.35M 0.68% 28
2026
Q1
$5.93M Buy
38,815
+1,157
+3% +$177K 0.74% 26
2025
Q4
$5.19M Sell
37,658
-5,873
-13% -$769K 0.68% 28
2025
Q3
$5.58M Buy
43,531
+1,448
+3% +$177K 0.65% 28
2025
Q2
$5.09M Buy
42,083
+2,090
+5% +$236K 0.63% 31
2025
Q1
$4.66M Sell
39,993
-532
-1% -$56.6K 0.56% 39
2024
Q4
$3.94M Sell
40,525
-9,837
-20% -$1.05M 0.48% 49
2024
Q3
$5.79M Buy
50,362
+531
+1% +$60.3K 0.81% 25
2024
Q2
$5.31M Buy
49,831
+2,473
+5% +$248K 0.79% 26
2024
Q1
$4.75M Buy
47,358
+6,139
+15% +$629K 0.78% 27
2023
Q4
$4.16M Buy
41,219
+8,116
+25% +$783K 0.84% 28
2023
Q3
$3.37M Buy
33,103
+2,469
+8% +$251K 0.81% 26
2023
Q2
$3.09M Buy
30,634
+4,001
+15% +$400K 0.79% 25
2023
Q1
$2.45M Buy
26,633
+391
+1% +$34.1K 0.86% 20
2022
Q4
$2.41M Buy
26,242
+2,426
+10% +$204K 0.66% 27
2022
Q3
$1.81M Buy
23,816
+1,900
+9% +$157K 0.74% 22
2022
Q2
$1.85M Buy
+21,916
New +$1.92M 0.76% 22

Other funds holding NVS

Naviter Wealth's NVS Position: Q2 2026 in Review

Naviter Wealth increased its Novartis (NVS) stake by 23% in Q2 2026, buying an estimated $1.35M and bringing the position to 47,793 shares worth $7.49M. The position accounts for 0.68% of the portfolio, ranked #28.

Naviter Wealth first reported a position in NVS in Q2 2022 and has held it in 17 quarters since. 1,623 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Naviter Wealth held 47,793 shares of Novartis worth $7.49M as of Q2 2026.
  • Naviter Wealth bought 8,978 Novartis shares in Q2 2026, an estimated $1.35M.
  • Novartis made up 0.68% of Naviter Wealth's portfolio in Q2 2026, its #28 holding.
  • Naviter Wealth first reported a position in Novartis in Q2 2022 and has held it in 17 quarters since.
  • 1,623 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Naviter Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.